Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
SG&A Expense Growth
-0.19%
Quarterly · Period ending:
BIO SG&A Expense Growth
Latest reported-0.19%period ending
Latest reported-0.19%period ending
BIO Quarterly SG&A Growth (QoQ) (0.00% → -0.19%)
Latest values, visible window
High-resolution chart · PNG
BIO sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -0.1883% | |
| -1.9391% | |
| 4.7389% | |
| -0.4333% | |
| -0.5268% | |
| 2.3529% | |
| 1.7761% | |
| 2.2033% | |
| -6.8243% | |
| 2.2278% | |
| 2.3345% | |
| -3.1878% | |
| -7.8602% | |
| 6.2791% | |
| 0.5591% | |
| 1.11% | |
| 6.1202% | |
| -12.2483% | |
| 3.6993% | |
| 1.2768% | |
| -5.5027% | |
| 3.0596% | |
| 10.5887% | |
| 4.7041% | |
| -2.2871% | |
| -9.5595% | |
| 6.221% | |
| 0.1814% | |
| -3.0465% | |
| -2.3346% | |
| 5.6398% | |
| -4.3859% | |
| 0.6192% | |
| 2.4113% | |
| 3.7796% | |
| -7.6319% | |
| 9.2782% | |
| -11.399% | |
| 9.2171% | |
| -1.987% | |
| 8.3388% | |
| -1.7754% | |
| 3.0409% | |
| -2.8002% | |
| 2.2752% | |
| -9.1463% | |
| 2.4621% | |
| 3.4273% | |
| -3.1823% | |
| -5.7362% | |
| 6.1047% | |
| 3.536% | |
| 5.0635% | |
| -1.6702% | |
| 17.9699% | |
| -1.2215% | |
| -5.2758% | |
| -2.0758% | |
| -1.0986% | |
| 0.0719% | |
| 5.351% | |
| -5.0427% | |
| 18.8478% | |
| -4.8736% | |
| 1.727% | |
| -6.2522% | |
| 6.665% | |
| 6.9277% | |
| 2.3925% | |
| -9.1808% | |
| 2.6435% | |
| 2.6488% | |
| 4.9973% | |
| -14.3168% | |
| 38.4945% | |
| -1.5592% | |
| 10.9522% | |
| -12.0142% | |
| 15.5857% | |
| -4.0881% | |
| 10.3887% | |
| -8.7169% | |
| 6.7044% | |
| -1.4239% | |
| 4.7478% | |
| -10.2206% | |
| 22.889% | |
| -0.0177% | |
| 1.929% | |
| -0.3682% | |
| 10.5319% | |
| 1.683% | |
| 2.4197% | |
| -4.1955% | |
| 9.7024% | |
| 5.6544% | |
| 5.8318% | |
| -15.2452% | |
| 15.2731% | |
| 2.8497% |